Emergent BioSolutions Announces Initiation of Phase Ib/II Study of TRU-016 in Combination with Bendamustine for Chronic Lymphocytic Leukemia
ROCKVILLE, Md., Jan 25, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced the initiation of a Phase Ib/II study (16201) of TRU-016 for chronic lymphocytic leukemia (CLL). TRU-016 is a CD37-directed Small Modular ImmunoPharmaceutical (SMIP(TM)) protein therapeutic in development for the treatment of B-cell malignancies. TRU-016 is [...]
In: Chief Executive Officer, El-Hibri, Emergent Bioslutions, Food and Drug Administration, Fuad El-Hibri, Leukemia, Leukemia & Lymphoma Society · Tagged with: American Society of Hematology, Bendamustine, Clinical trial, Emergent Biosolutions Inc, Leukemia, Leukemia & Lymphoma Society, Lymphocyte
CEO took roundabout path to Emergent
By Marjorie Censer
Monday, January 3, 2011
Fuad El-Hibri has lived in all sorts of exotic locales, working for Citicorp in Saudi Arabia, consulting for Booz Allen Hamilton in Indonesia and establishing mobile telecommunications businesses in Russia, Venezuela and El Salvador.
But getting started in his current position as chief executive of Rockville-based pharmaceutical company Emergent BioSolutions took [...]
In: Chief Executive Officer, El-Hibri, Emergent Bioslutions, Food and Drug Administration, Fuad El-Hibri, U.S. Food and Drug Administration, United States, Yale university · Tagged with: Chief executive officer, DEPARTMENT OF HEALTH AND HUMAN SERVICES, El-Hibri, Emergent Biosolutions Inc, entrepreneur, Rockville
Emergent BioSolutions to Participate in June 2010 Investor Conferences
Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the company will be participating in the following investor conferences during June 2010:
The Jefferies & Company 2010 Global Life Sciences Conference
New [...]
In: Business, Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, Healthcare Conference · Tagged with: Business, Emergent Biosolutions Inc, Fuad El-Hibri, Healthcare Conference, Jefferies & Company, United States, Webcast